Fundalysisby DARKHORSESTOCKS

Stock · INE935A01035

Glenmark Pharmaceuticals

Held by 157 schemes worth ₹7,893 Cr in Sept 2026.

Schemes holding Glenmark Pharmaceuticals(Sept 2012 – Sept 2026)

Schemes holding Glenmark Pharmaceuticals in Sept 2026. Tick up to 2 to plot them.
Plot157 schemes · ₹ Cr
HDFC Mid Cap Fund
3,130
Invesco India Mid cap Fund
435
Invesco India Contra Fund
397
Invesco India Large Mid Cap Fund
314
ICICI Prudential Arbitrage Fund
246
HDFC Large Mid Cap Fund
245
SBI Arbitrage Fund
224
Kotak Arbitrage Fund
223
HDFC Balanced Advantage Fund
207
Mirae Asset Healthcare Fund
167
Nippon India Arbitrage Fund
164
Tata Mid Cap Fund
140
HDFC Manufacturing Fund
134
Aditya Birla Sun Life Arbitrage Fund
131
HDFC Arbitrage Fund
116
Tata Arbitrage Fund
105
Axis Arbitrage Fund
94.6
Axis Multicap Fund
90.1
quant ELSS Tax Saver Fund
84.6
Axis Large Mid Cap Fund
75.8
HDFC Pharma and Healthcare Fund
73.1
Nippon India Nifty Pharma ETF
61.9
Aditya Birla Sun Life quant Fund
56.2
Invesco India Arbitrage Fund
55.7
DSP Arbitrage Fund
49.6
Mirae Asset Aggressive Hybrid Fund
42.7
HSBC Arbitrage Fund
35.3
Bank of India Aggressive Hybrid Fund
35
Motilal Oswal Nifty Midcap 150 Index Fund
34.6
Nippon India ETF Nifty Midcap 150
33.2
Baroda BNP Paribas Arbitrage Fund
32.6
HDFC Dividend Yield Fund
30.4
Axis India Manufacturing Fund
27.7
Tata Nifty Midcap 150 Momentum 50 Index Fund
25.9
Nippon India Nifty Midcap 150 Index Fund
23.3
Invesco India Pharma and Healthcare Fund
21.2
Nippon India Nifty 500 Momentum 50 Index Fund
21.1
Baroda BNP Paribas Innovation Fund
21
Invesco India Business Cycle Fund
18
Kotak Balanced Advantage Fund
16.6
Mirae Asset Arbitrage Fund
16.3
Mirae Asset Nifty Midcap 150 ETF
15.7
Motilal Oswal Nifty 200 Momentum 30 Index Fund
15.4
Baroda BNP Paribas Health and Wellness Fund
15.2
Old Bridge Flexi Cap Fund
13.1
Motilal Oswal Nifty 500 Momentum 50 Index Fund
13
Parag Parikh Arbitrage Fund
13
Bank of India Business Cycle Fund
12.8
Axis Nifty Midcap 50 Index Fund
12
Tata Nifty MidSmall Healthcare Index Fund
11.9
  • HDFC Mid Cap Fund
  • Invesco India Mid cap Fund
Market value of Glenmark Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthHDFC Mid Cap FundInvesco India Mid cap Fund
Sept 2025₹2,435 Cr₹327 Cr
Oct 2025₹2,390 Cr₹353 Cr
Nov 2025₹2,459 Cr₹363 Cr
Dec 2025₹2,572 Cr₹379 Cr
Jan 2026₹2,555 Cr₹376 Cr
Feb 2026₹2,738 Cr₹398 Cr
Mar 2026₹2,732 Cr₹397 Cr
Apr 2026₹3,226 Cr₹449 Cr
May 2026₹3,050 Cr₹424 Cr
Jun 2026₹2,956 Cr₹411 Cr
Jul 2026₹2,995 Cr₹416 Cr
Aug 2026₹3,325 Cr₹462 Cr
Sept 2026₹3,130 Cr₹435 Cr
Fig. 1.Market value of Glenmark Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

25 fund houses% of total
HDFC
1550.15
INVESCO
615.72
Axis
103.94
ICICI
133.93
Nippon
63.86
Tata
63.63
Kotak
133.52
Mirae
163.44
SBI
73.06
Aditya Birla
62.57
Other fund houses
596.18

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Glenmark Pharmaceuticals(Oct 2025 – Sept 2026)

Schemes buying and selling Glenmark Pharmaceuticals. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.